Vaxcyte recently began dosing participants in OPUS, its FDA-aligned Phase 3 pivotal noninferiority trial of VAX-31 for preventing invasive pneumococcal disease and pneumonia in adults, enrolling about ...

Trial Design Finalized in Consultation and Alignment with U.S. Food and Drug Administration Study Designed to Establish a New Standard for Adult ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. Pfizer’s 20-valent pneumococcal conjugate vaccine ...

PCV15 and PCV20 are still too new to have good data on how effective they are in widespread use. Pneumococcal vaccines should offer ongoing protection, perhaps for life. The need for an additional ...

Pfizer has launched its most advanced 20-valent pneumococcal conjugate vaccine, PCV20, for adults in India. This breakthrough represents a significant advancement in prophylactic medicine, providing ...

The 20-valent pneumococcal conjugate vaccine (PCV20, or Prevnar 20) produced a non-inferior immune response in adults to the 13-valent vaccine (PCV13, or Prevnar 13), with an adequate safety profile, ...

The CDC's Advisory Committee on Immunization Practices (ACIP) agreed unanimously on Thursday to include the 20-valent pneumococcal conjugate vaccine (PCV20; Prevnar) as an option for U.S. children.

Please provide your email address to receive an email when new articles are posted on . The Advisory Committee on Immunization Practices unanimously agreed to recommend PCV20 for children. Advisors ...

RAHWAY, N.J.--(BUSINESS WIRE)--Merck (NYSE: MRK), known as MSD outside of the United States and Canada, today announced results from STRIDE-3, a Phase 3 trial evaluating V116, the company’s ...

Findings presented at IDWeek 2025 underscore the importance of considering serotypes that disproportionately impact adults in the U.S. and show greater resistance to commonly prescribed antibiotics ...

Pneumococcus is a major bacterial pathogen that causes various diseases such as otitis media, pneumonia, and meningitis in infants and young children. In particular, it can cause invasive pneumococcal ...